Metabotropic glutamate receptors (mGluRs) couple the actions of glutamate to intracellular second messenger systems through G-proteins. The mGluRs play an important role in the regulation of basal ganglia function. Ligand binding studies have revealed that the basal ganglia contain at least two pharmacological types of metabotropic binding sites. Agonists of mGluRs can affect both in vitro electrophysiologic responses of striatal neurons and motor behavior in vivo. Recently, cDNAs encoding five mGluRs have been cloned, each with distinct structural and pharmacological properties. In order to elucidate the function of these receptors in the biology of the extrapyramidal motor system, we have used in situ hybridization to examine the regional and cellular expression patterns of mGluR1-mGluR5 in the adult rat basal ganglia. In the striatum, all of these mGluRs were present in widely varying relative densities and cellular patterns. MGluR5 was particularly prominent, and exhibited a heterogeneous cellular distribution, with labeled and unlabeled populations of neurons. MGluR2 was expressed in a small population of large polygonal striatal neurons. The subthalamic nucleus was the only other basal ganglia structure that expressed mGluR2. Distinct cellular distributions of mGluR expression were also observed within the nucleus accumbens, globus pallidus, ventral pallidum, and substantia nigra pars reticulata. MGluR3 was expressed in glia in all basal ganglia structures, but was observed in neurons only in the striatum, substantia nigra pars reticulata, and very weakly in the subthalamic nucleus. Comparison of the restricted mGluR2 and mGluR3 mRNA distributions with that of metabotropic ligand binding sites supports a possible presynaptic location for these receptors in the basal ganglia. MGluR1 was the only mGluR message prominently expressed in the dopaminergic neurons of the substantia nigra pars compacta, suggesting the involvement of this receptor in the regulation of dopamine release from nigrostriatal terminals.

N-Methyl-D-aspartate (NMDA) receptors are enriched in the neostriatum and are thought to mediate several actions of glutamate including neuronal excitability, long-term synaptic plasticity, and excitotoxic injury. NMDA receptors are assembled from several subunits (NMDAR1, NMDAR2A-D) encoded by five genes; alternative splicing gives rise to eight isoforms of subunit NMDAR1. We studied the expression of NMDA receptor subunits in neurochemically identified striatal neurons of adult rats by in situ hybridization histochemistry using a double- labeling technique. Enkephalin-positive projection neurons, somatostatin-positive interneurons, and cholinergic interneurons each have distinct NMDA receptor subunit phenotypes. Both populations of striatal interneurons examined express lower levels of NMDAR1 and NMDAR2B subunit mRNA than enkephalin-positive neurons. The three striatal cell populations differ also in the presence of markers for alternatively spliced regions of NMDAR1, suggesting that interneurons preferentially express NMDAR1 splice forms lacking one (cholinergic neurons) or both (somatostatin-positive neurons) alternatively spliced carboxy-terminal regions. In addition, somatostatin- and cholinergic-, but not enkephalin-positive neurons express NMDAR2D mRNA. Thus, these striatal cell populations express different NMDAR-subunit mRNA phenotypes and therefore are likely to display NMDA channels with distinct pharmacological and physiological properties. Differences in NMDA receptor expression may contribute to the relative resistance of striatal interneurons to the neurotoxic effect of NMDA receptor agonists.

The parabrachial nucleus (PB) is the major relay for ascending visceral afferent information from the nucleus of the solitary tract to the forebrain. We have recently found that PB in the rat also receives a substantial afferent projection from neurons in the marginal zone of the entire length of the spinal and trigeminal dorsal horn. Immunoreactive perikarya stained with antisera against several neuropeptides -including dynorphin, efikephalins, and substance P-have been identified in the marginal zone. We therefore investigated the chemical specificity of the spinoparabrachial projection by combining fluorescent retrograde tracing with immunofluorescence for substance P, dynorphin Al -17, met-enkephalin, and two enkephalin precursor fragments (proenkephalin 192-203 and peptide E).Following PB injections of fluorescent dyes, about half of the retrogradely labeled neurons in the marginal zone stained with antisera against either dynorphin or enkephalin series peptides. Elution-restaining experiments indicated that the dynorphinand enkephalin-immunoreactivities were contained within separate populations of marginal zone neurons. We could not identify any substance P-immunoreactive perikarya in the marginal zone, but substance P-immunoreactive fibers were seen in close apposition to retrogradely labeled, opioid-immunoreactive cell bodies and dendrites.These results indicate that the dynorphin-and enkephalinimmunoreactive perikarya in the marginal zone of the dorsal horn represent independent neuronal populations. These opioidimmunoreactive neurons, which are believed to have extensive local collateral connections, are the main source of a long ascending projection to the parabrachial nucleus in the rat. Furthermore, opioid neurons in the marginal zone may receive substance P-immunoreactive primary sensory afferents.The parabrachial nucleus (PB) is an important relay for visceral afferent information traveling from the nucleus of the solitary tract to the forebrain. Early studies of ascending spinal cord pathways using anterograde degeneration after spinal lesions

The paraventricular nucleus of the hypothalamus (PVH) contains a prominent collection of varicose atriopeptin-like immunoreactive (APir) fibers. We have used immunohistochemistry and fluorescent retrograde tracers to investigate the origin of these fibers. All parts of the PVH contain APir fibers. The densest collections are found in the periventricular area and in the parvocellular components of the nucleus. Somewhat smaller numbers of fibers are found within the borders of the magnocellular part of the PVH. Following the injection of fluorescent retrograde tracers into the PVH and subsequent immunohistochemical staining, numerous retrogradely labeled APir neurons were observed in the anteroventral periventricular nucleus (AVPV), adjacent to the anteroventral tip of the third ventricle. Smaller groups of retrogradely labeled APir neurons were observed in the ventromedial part of the bed nucleus of the stria terminalis, the pedunculopontine and laterodorsal tegmental nuclei, and the medial part of the nucleus of the solitary tract. The APir projection from the AVPV to the PVH is of particular interest in view of the abundant evidence implicating both regions in the regulation of the fluid and electrolyte balance and blood pressure. AP may serve as a central neuromodulator as well as a circulating hormone in cardiovascular regulation.

cDNAs encoding four isoforms of the human NMDA receptor (NMDAR) NMDAR2C (hNR2C-1, -2, -3, and -4) have been isolated and characterized. The overall identity of the deduced amino acid sequences of human and rat NR2C-1 is 89.0%. The sequences of the rat and human carboxyl termini (G1y 925-Va11236) are encoded by different exons and are only 71.5% homologous. In situ hybridization in human brain revealed the expression of the NR2C mRNA in the pontine reticular formation and lack of expression in substantia nigra pars compacta in contrast to the distribution pattern observed previously in rodent brain. The pharmacological properties of hNR1A/2C were determined by measuring agonist-induced inward currents in Xenopus oocytes and compared with those of other human NMDAR subtypes. Glycine, glutamate, and NMDA each discriminated between hNR1A/2C-1 and at least one of hNR1A/2A, hNR1A/2B, or hNR1A/2D subtypes. Among the antagonists tested, CGS 19755 did not significantly discriminate between any of the four subtypes, whereas 5,7-dichlorokynurenic acid distinguished between hNR1A/2C and hNR1A/2D. Immunoblot analysis of membranes isolated from HEK293 cells transiently transfected with cDNAs encoding hNR1A and each of the four NR2C isoforms indicated the formation of heteromeric complexes between hNR1A and all four hNR2C isoforms. HEK293 cells expressing hNR1A/ 2C-3 or hNR1A/2C-4 did not display agonist responses. In contrast, we observed an agonist-induced elevation of intracellular free calcium and whole-cell currents in cells expressing hNR1A/2C-1 or hNR1A/2C-2. There were no detectable differences in the macroscopic biophysical properties of hNR1A/2C-1 or hNR1A/2C-2. Key Words: Cloning -Isoforms-N-Methyl-o-aspartate-Brain distribution-Biophysical properties-Pharmacology. J. Neurochem. 71, 1953Neurochem. 71, -1968Neurochem. 71, (1998.There is evidence that NMDA receptors (NMDARs) are involved in the induction and maintenance of longterm potentiation, synaptic integration, synaptogenesis, and developmental structuring of the mammalian CNS (Morris, 1989;Bliss and Collingridge, 1993) and in some forms of neuronal excitotoxicity (for review, see Rothman and Olney, 1995). Five NMDAR subunit cDNAs (NR1, NR2A, NR2B, NR2C, NR2D) have been cloned from rat and mouse (for review, see Mon and Mishina, 1995). in addition, several splice variants of the NRI gene have been cloned. Recombinant NMDARs have been functionally expressed in several host systems, and their biophysical and pharmacological properties have been characterized in detail (for review, see Hollmann and Heinemann, 1994;Mon and Mishina, 1995). The human (h) hNRIA, hNR2A, hNR2B, hNR2C, and hNR2D cDNAs have also been cloned (Karp et al., 1993;Le Bourdellès et al., 1994;Adams et al., 1995;Hess et al., 1996Hess et al., , 1998Lin et al., 1996).In this study, we describe the isolation and characterization of four isoforms of human NMDAR2C cDNAs (hNR2C-1, -2, -3, and -4). We identified a sequence divergence between human and rat cDNAs in the carboxyl-terminal regio...